Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | LNTH-2403 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on LNTH-2403, a putative LRRC15-targeted radiotherapeutic (Feb 2026). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| LNTH-2403 | LNTH2403|LNTH 2403 | Limited information is currently available on LNTH-2403, a putative LRRC15-targeted radiotherapeutic (Feb 2026). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07357519 | Phase Ib/II | LNTH-2403 | Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy) | Recruiting | USA | 0 |